One of the concerted actors and the controlling shareholder of Gu Han Medicine, Shanghai Sailaxian, plans to increase its holdings in the company by no less than 20 million yuan

NightAirdropper · 2026-03-11T12:58:53+00:00

Guhanhai Medicine announced that one of its controlling shareholders' concerted action partner, Shanghai Sailuxian, plans to increase its stake in the company within the next 6 months, with an investment of no less than 20 million yuan, demonstrating recognition of the company's long-term investment value. Before the increase, the total shareholding was 24.93%.

NightAirdropper

2026-03-11 12:58:53

Abstract generation in progress

Beijing Business Daily (Reporter Ding Ning) reported that on the evening of March 9, Guhuan Medicine (000590) announced that one of its controlling shareholders’ concerted action partners, Shanghai Sailuxian Enterprise Management Consulting Co., Ltd. (hereinafter referred to as “Shanghai Sailuxian”), based on recognition of the company’s long-term investment value and confidence in its future sustainable development, plans to increase its holdings within 6 months from the date of the announcement, with a total planned increase of no less than 20 million yuan.

The announcement shows that before this increase, Shanghai Sailuxian and the company’s controlling shareholder, Hunan Sailuxian Management Consulting Partnership (Limited Partnership), together held 59.707 million shares, accounting for 24.93% of the company’s total share capital.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.